Australia, Feb. 10 -- Corcept Therapeutics Inc., owns the trademark (2561847) for 'ONFARLA' till June 30, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders]
Type of Mark: Word
Date of Acceptance: Aug. 13, 2025
Registration Advertised: Feb. 9
For further details contact ALLENS PATE...